Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

TABLE 1s. Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending July 17, 2021 (Week 28)
Reporting Area Invasive pneumococcal disease, all ages §
Confirmed Probable
Current weekPrevious 52 weeks Max †Cum YTD 2021 †Cum YTD 2020 †Current weekPrevious 52 weeks Max †Cum YTD 2021 †Cum YTD 2020 †
U.S. Residents, excluding U.S. Territories 57 180 3,726 7,706 1 9 78 120
New England - 18 155 471 - 1 - 4
Connecticut - 5 31 122 - 0 - 1
Maine - 9 39 58 - 0 - -
Massachusetts - 5 54 183 - 1 - -
New Hampshire - 3 18 54 - 0 - 2
Rhode Island - 3 11 33 - 0 - -
Vermont - 1 2 21 - 1 - 1
Middle Atlantic 5 33 450 1,047 1 6 31 36
New Jersey 3 11 75 300 1 3 18 24
New York (excluding New York City) - 19 156 320 - 1 5 8
New York City 2 14 166 348 - 6 7 1
Pennsylvania - 6 53 79 - 1 1 3
East North Central - 37 693 1,437 - 2 12 32
Illinois N NC N N N NC N N
Indiana - 14 165 278 - 1 - 1
Michigan - 11 134 361 - 1 4 1
Ohio - 19 291 591 - 1 8 30
Wisconsin - 8 103 207 - 0 - -
West North Central 2 14 169 411 - 2 7 7
Iowa N NC N N N NC N N
Kansas - 0 - - - 0 - -
Minnesota - 1 - - - 0 - -
Missouri - 10 125 270 - 2 7 5
Nebraska 2 4 29 73 - 0 - 2
North Dakota - 3 15 37 - 1 - -
South Dakota - 1 - 31 - 0 - -
South Atlantic 21 37 731 1,293 - 2 8 13
Delaware 1 3 28 42 - 0 - -
District of Columbia - 2 8 42 - 0 - -
Florida 13 24 300 426 - 2 5 7
Georgia 1 16 215 337 - 0 - -
Maryland 6 8 104 224 - 1 2 -
North Carolina N NC N N N NC N N
South Carolina - 8 17 80 - 1 1 3
Virginia - 1 8 7 - 0 - -
West Virginia - 8 51 135 - 0 - 3
East South Central 3 28 429 816 - 1 3 4
Alabama 1 12 119 188 - 0 - -
Kentucky 2 5 57 173 - 1 3 2
Mississippi - 7 70 127 - 0 - -
Tennessee - 15 183 328 - 0 - 2
West South Central 9 55 430 875 - 3 10 16
Arkansas 3 10 59 144 - 1 - 1
Louisiana - 13 123 184 - 1 - 3
Oklahoma N NC N N N NC N N
Texas 6 46 248 547 - 3 10 12
Mountain 12 45 593 1,231 - 2 7 3
Arizona 7 37 325 461 - 1 2 1
Colorado - 12 - 245 - 0 - -
Idaho N NC N N N NC N N
Montana - 4 33 58 - 0 - 2
Nevada - 8 70 190 - 1 2 -
New Mexico 2 7 85 146 - 0 - -
Utah 3 9 68 111 - 1 3 -
Wyoming - 2 12 20 - 0 - -
Pacific 5 10 76 125 - 1 - 5
Alaska 5 10 66 97 - 1 - 5
California N NC N N N NC N N
Hawaii - 2 10 28 - 0 - -
Oregon N NC N N N NC N N
Washington N NC N N N NC N N
U.S. Territories - 0 - - - 0 - -
American Samoa N NC N N N NC N N
Commonwealth of Northern Mariana Islands - 0 - - - 0 - -
Guam - 0 - - - 0 - -
Puerto Rico - 0 - - - 0 - -
U.S. Virgin Islands - 0 - - - 0 - -
Non-U.S. Residents - 0 - - - 0 - -
Total 57 180 3,726 7,706 1 9 78 120
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • Max: Maximum — Maximum case count during the previous 52 weeks.
  • * Case counts for reporting years 2020 and 2021 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/docs/Readers-Guide-WONDER-Tables-20210421-508.pdf.
  • †Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Includes drug resistant and susceptible cases of Invasive Pneumococcal Disease.